DAF-16と熱ショック因子による老化および年齢関連の疾患の調節
Ao-Lin Hsu1, Coleen T Murphy, Cynthia Kenyon
1Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-2200, USA.
まとめ
C. elegans の熱ショック因子 HSF-1 は,老化に影響する. その過剰発現は寿命を延ばし,長寿遺伝子を活性化するためにDAF-16と作用し,潜在的に年齢関連の疾患を遅らせます.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- 老化に関する研究.
背景:
- 熱ショック反応は,転写因子HSF-1によって調節される.
- HSF-1は,Caenorhabditis elegans.の老化プロセスに役割を果たしています.
- DAF-16は,寿命に影響することが知られているもう一つの転写因子です.
研究 の 目的:
- 老化と寿命の調節におけるHSF-1の役割を調査する.
- HSF-1,DAF-16,および長寿経路の関係を決定する.
- HSF-1,小型の熱ショックタンパク質,および年齢関連の疾患の関連性を調査する.
主な方法:
- C. elegans.におけるHSF-1の活性 (減少と過剰表現) の遺伝子操作
- 変化したHSF-1レベルに対する寿命の分析.
- 寿命を延ばすため,ダフ-2変異の遺伝的要件を調査し,HSF-1とDAF-16.6に焦点を当てました.
主要な成果:
- hsf-1の活性が低下すると,老化を加速し,寿命が短縮されます.
- HSF-1の過剰発現は,C. elegansの寿命を延長する.
- HSF-1は,DAF-16と共に,Daf-2変異が寿命を延長するために不可欠です.
- HSF-1とDAF-16は,小型の熱ショックタンパク質を含む遺伝子を共活性化し,長寿を促進します.
結論:
- HSF-1は,C. elegansの老化と寿命の重要な調節因子である.
- HSF-1とDAF-16の協同作用は長寿に不可欠です.
- HSF-1とDAF-16によって活性化される小型の熱ショックタンパク質は,寿命延長の重要な媒介であり,タンパク質集積疾患から保護することができます.
関連する概念動画
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


